Toll-like receptor signaling in neural plasticity and disease

Trends in Neurosciences

Volumn 34, Issue 5, 2011, Pages 269-281

  Okun, Eitan ^a   Griffioen, Kathleen J ^a   Mattson, Mark P ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; BETA TUBULIN; DOUBLE STRANDED RNA; DOUBLECORTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 9; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 27; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; NERVE GROWTH FACTOR; STAT1 PROTEIN; STAT2 PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 11; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; COGNITION; CPG ISLAND; DENDRITIC CELL; DROSOPHILA MELANOGASTER; GENE DELETION; HERPES SIMPLEX ENCEPHALITIS; HUMAN; MULTIPLE SCLEROSIS; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEURITE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; BRAIN; BRAIN DISEASES; HUMANS; MODELS, NEUROLOGICAL; NERVE NET; NEURONAL PLASTICITY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 79955745301     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2011.02.005     Document Type: Review

References (105)

1. Kawai T., Akira S. TLR signaling. Seminars Immunol. 2007, 19:24-32.
2. Valanne S., et al. The Drosophila toll signaling pathway. J. Immunol. 2011, 186:649-656.
3. Okun E., et al. Toll-like receptors in neurodegeneration. Brain Res. Rev. 2009, 59:278-292.
4. Leulier F., et al. Toll-like receptors: taking an evolutionary approach. Nat. Rev. 2008, 9:165-178.
5. Vijay-Kumar M., et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010, 328:228-231.
6. Gerondakis S., et al. Regulating B-cell activation and survival in response to TLR signals. Immunol. Cell Biol. 2007, 85:471-475.
7. Iwamura C., Nakayama T. Toll-like receptors in the respiratory system: their roles in inflammation. Curr. Allergy Asthma Rep. 2008, 8:7-13.
8. Eriksson M., et al. TLRs mediate IFN-gamma production by human uterine NK cells in endometrium. J. Immunol. 2006, 176:6219-6224.
9. Sutmuller R., et al. Regulatory T cells and toll-like receptors: regulating the regulators. Ann. Rheum. Dis. 2007, 66(Suppl 3):iii91-iii95.
10. Kaisho T., Akira S. Toll-like receptor function and signaling. J. Allergy Clin. Immunol. 2006, 117:979-987. quiz 988.
11. Sabroe I., Whyte M.K. Toll-like receptor (TLR)-based networks regulate neutrophilic inflammation in respiratory disease. Biochem. Soc. Trans. 2007, 35(Pt 6):1492-1495.
12. Yoshimoto T., Nakanishi K. Roles of IL-18 in basophils and mast cells. Allergol. Int. 2006, 55:105-113.
13. Gibson F.C.III, et al. Engagement of specific innate immune signaling pathways during Porphyromonas gingivalis induced chronic inflammation and atherosclerosis. Front. Biosci. 2008, 13:2041-2059.
14. Olson J.K., Miller S.D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 2004, 173:3916-3924.
15. Bowman C.C., et al. Cultured astrocytes express toll-like receptors for bacterial products. Glia 2003, 43:281-291.
16. Aravalli R.N., et al. Toll-like receptors in defense and damage of the central nervous system. J. Neuroimm. Pharmacol. 2007, 2:297-312.
17. Tang S.C., et al. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:13798-13803.
18. Uematsu S., et al. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat. Immunol. 2008, 9:769-776.
19. Smith K.D., et al. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat. Immunol. 2003, 4:1247-1253.
20. Kucera K., et al. Structure-based analysis of Toxoplasma gondii profilin: a parasite-specific motif is required for recognition by Toll-like receptor 11. J. Mol. Biol. 2010, 403:616-629.
21. Miyake K. Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Seminars Immunol. 2007, 19:3-10.
22. Schon M.P., Schon M. TLR7 and TLR8 as targets in cancer therapy. Oncogene 2008, 27:190-199.
23. Pandey S., Agrawal D.K. Immunobiology of Toll-like receptors: emerging trends. Immunol. Cell Biol. 2006, 84:333-341.
24. Lehnardt S., et al. A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. J. Neurosci. 2008, 28:2320-2331.
25. Liu Y., et al. CD24-Siglec G/10 discriminates danger- from pathogen-associated molecular patterns. Trends Immunol. 2009, 30:557-561.
26. Shimada M., et al. Hyaluronan fragments generated by sperm-secreted hyaluronidase stimulate cytokine/chemokine production via the TLR2 and TLR4 pathway in cumulus cells of ovulated COCs, which may enhance fertilization. Development 2008, 135:2001-2011.
27. Hemmi H., Akira S. TLR signalling and the function of dendritic cells. Chem. Immunol. Allergy 2005, 86:120-135.
28. Gorina R., et al. Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFkappaB signaling MAPK, and Jak1/Stat1 pathways. Glia 2011, 59:242-255.
29. Jung D.Y., et al. TLR4, but not TLR2, signals autoregulatory apoptosis of cultured microglia: a critical role of IFN-beta as a decision maker. J. Immunol. 2005, 174:6467-6476.
30. Divanovic S., et al. Inhibition of TLR-4/MD-2 signaling by RP105/MD-1. J. Endotoxin Res. 2005, 11:363-368.
31. Mattson M.P., et al. A neural signaling triumvirate that influences ageing and age-related disease: insulin/IGF-1 BDNF and serotonin. Ageing Res. Rev. 2004, 3:445-464.
32. Mattson M.P., et al. Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell Biol. 1995, 46:187-216.
33. Mattson M.P., et al. Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 1997, 49:681-697.
34. Lathia J.D., et al. The microenvironment of the embryonic neural stem cell: lessons from adult niches?. Dev. Dyn. 2007, 236:3267-3282.
35. Duan X., et al. Development of neural stem cell in the adult brain. Curr. Opin. Neurobiol. 2008, 18:108-115.
36. Lathia J.D., et al. Toll-like receptor 3 is a negative regulator of embryonic neural progenitor cell proliferation. J. Neurosci. 2008, 28:13978-13984.
37. Okun E., et al. TLR2 activation inhibits embryonic neural progenitor cell proliferation. J. Neurochem. 2010, 114:462-474.
38. Rolls A., et al. Toll-like receptors modulate adult hippocampal neurogenesis. Nat. Cell Biol. 2007, 9:1081-1088.
39. Shechter R., et al. Toll-like receptor 4 restricts retinal progenitor cell proliferation. J. Cell Biol. 2008, 183:393-400.
40. Covacu R., et al. TLR activation induces TNF-alpha production from adult neural stem/progenitor cells. J. Immunol. 2009, 182:6889-6895.
41. Sloane J.A., et al. Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:11555-11560.
42. Okun E., et al. Toll-like receptor 3 inhibits memory retention and constrains adult hippocampal neurogenesis. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:15625-15630.
43. Ma Y., et al. Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J. Cell Biol. 2006, 175:209-215.
44. Ma Y., et al. TLR8: an innate immune receptor in brain, neurons and axons. Cell Cycle 2007, 6:2859-2868.
45. Cameron J.S., et al. Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J. Neurosci. 2007, 27:13033-13041.
46. Acosta C., Davies A. Bacterial lipopolysaccharide regulates nociceptin expression in sensory neurons. J. Neurosci. Res. 2008, 86:1077-1086.
47. Iliev A.I., et al. Neuronal injury mediated via stimulation of microglial toll-like receptor-9 (TLR9). FASEB J. 2004, 18:412-414.
48. Okun E., et al. Adhesion- and migration-related side effects of phosphothioated CpG oligodeoxynucleotides. Cell Adh. Migr. 2009, 3:272-274.
49. Okun E., Mattson M.P. Phosphothioated oligodeoxynucleotides induce nonspecific effects on neuronal cell adhesion in a growth substrate-dependent manner. J. Neurosci. Res. 2009, 87:1947-1952.
50. Trudler D., et al. Toll-like receptors expression and signaling in glia cells in neuro-amyloidogenic diseases: towards future therapeutic application. Mediators Inflamm. 2010, 10.1155/2010/497987.
51. Kariko K., et al. mRNA is an endogenous ligand for Toll-like receptor 3. J. Biol. Chem. 2004, 279:12542-12550.
52. Bsibsi M., et al. The microtubule regulator stathmin is an endogenous protein agonist for TLR3. J. Immunol. 2010, 184:6929-6937.
53. Yirmiya R., Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav. Immun. 2011, 25:181-213.
54. Weiner H.L., Frenkel D. Immunology and immunotherapy of Alzheimer's disease. Nat. Rev. Immunol. 2006, 6:404-416.
55. Tanaka S., et al. Lipopolysaccharide-induced microglial activation induces learning and memory deficits without neuronal cell death in rats. J. Neurosci. Res. 2006, 83:557-566.
56. Palin K., et al. The type 1 TNF receptor and its associated adapter protein FAN, are required for TNFalpha-induced sickness behavior. Psychopharmacology 2009, 201:549-556.
57. Tauber S.C., et al. Stimulation of Toll-like receptor 9 by chronic intraventricular unmethylated cytosine-guanine DNA infusion causes neuroinflammation and impaired spatial memory. J. Neuropathol. Exp. Neurol. 2009, 68:1116-1124.
58. Bauer S., et al. Pattern recognition by Toll-like receptors. Adv. Exp. Med. Biol. 2009, 653:15-34.
59. Schaffler A., Scholmerich J. Innate immunity and adipose tissue biology. Trends Immunol. 2010, 31:228-235.
60. Lehnardt S. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia 2010, 58:253-263.
61. Suh H.S., et al. Toll-like receptors in CNS viral infections. Curr. Top. Microbiol. Immunol. 2009, 336:63-81.
62. Baker B.J., et al. IL-27 inhibits OSM-mediated TNF-alpha and iNOS gene expression in microglia. Glia 2010, 58:1082-1093.
63. Bsibsi M., et al. Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia 2006, 53:688-695.
64. Kim H., et al. Double-stranded RNA mediates interferon regulatory factor 3 activation and interleukin-6 production by engaging Toll-like receptor 3 in human brain astrocytes. Immunology 2008, 124:480-488.
65. Klein M., et al. Innate immunity to pneumococcal infection of the central nervous system depends on toll-like receptor (TLR) 2 and TLR4. J. Infect. Dis. 2008, 198:1028-1036.
66. Sorensen L.N., et al. TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain. J. Immunol. 2008, 181:8604-8612.
67. Zhang S.Y., et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007, 317:1522-1527.
68. Wang T., et al. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 2004, 10:1366-1373.
69. Daffis S., et al. Toll-like receptor 3 has a protective role against West Nile virus infection. J. Virol. 2008, 82:10349-10358.
70. Szretter K.J., et al. The innate immune adaptor molecule MyD88 restricts West Nile virus replication and spread in neurons of the central nervous system. J. Virol. 2010, 84:12125-12138.
71. Szretter K.J., et al. The immune adaptor molecule SARM modulates tumor necrosis factor alpha production and microglia activation in the brainstem and restricts West Nile Virus pathogenesis. J. Virol. 2009, 83:9329-9338.
72. O'Neill L.A. DisSARMing Toll-like receptor signaling. Nat. Immunol. 2006, 7:1023-1025.
73. Erridge C. Endogenous ligands of TLR2 and TLR4: agonists or assistants?. J. Leukoc. Biol. 2010, 87:989-999.
74. Boksa P. Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain Behav. Immun. 2010, 24:881-897.
75. Caso J.R., et al. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 2007, 115:1599-1608.
76. Hua F., et al. Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion. J. Neuroimmunol. 2007, 190:101-111.
77. Lehnardt S., et al. Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia. J. Neuroimmunol. 2007, 190:28-33.
78. Kilic U., et al. TLR-4 deficiency protects against focal cerebral ischemia and axotomy-induced neurodegeneration. Neurobiol. Dis. 2008, 31:33-40.
79. Hyakkoku K., et al. Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia. Neuroscience 2010, 171:258-267.
80. Pradillo J.M., et al. Toll-like receptor 4 is involved in neuroprotection afforded by ischemic preconditioning. J. Neurochem. 2009, 109:287-294.
81. Yang Q.W., et al. HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signaling. J. Cereb. Blood Flow Metab. 2011, 31:593-605.
82. Park C., et al. Toll-like receptor 2 contributes to glial cell activation and heme oxygenase-1 expression in traumatic brain injury. Neurosci. Lett. 2008, 431:123-128.
83. Clark A.K., et al. P2X7-dependent release of interleukin-1beta and nociception in the spinal cord following lipopolysaccharide. J. Neurosci. 2010, 30:573-582.
84. Liu T., et al. Toll-like receptor 7 mediates pruritus. Nat. Neurosci. 2010, 13:1460-1462.
85. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 2004, 430:631-639.
86. Richard K.L., et al. Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease. J. Neurosci. 2008, 28:5784-5793.
87. Chen K., et al. Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide. J. Biol. Chem. 2006, 281:3651-3659.
88. Tahara K., et al. Role of toll-like receptor signalling in Abeta uptake and clearance. Brain 2006, 129(Pt 11):3006-3019.
89. Reed-Geaghan E.G., et al. CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation. J. Neurosci. 2009, 29:11982-11992.
90. Doi Y., et al. Microglia activated with the toll-like receptor 9 ligand CpG attenuate oligomeric amyloid {beta} neurotoxicity in in vitro and in vivo models of Alzheimer's disease. Am. J. Pathol. 2009, 175:2121-2132.
91. Scholtzova H., et al. Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology. J. Neurosci. 2009, 29:1846-1854.
92. Jin J.J., et al. Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease. J. Neuroinflammation 2008, 5:23.
93. Walter S., et al. Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease. Cell. Physiol. Biochem. 2007, 20:947-956.
94. Tang S.C., et al. Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal. Exp. Neurol. 2008, 213:114-121.
95. Minoretti P., et al. Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease. Neurosci. Lett. 2006, 391:147-149.
96. Soulika A.M., et al. Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis. J. Neurosci. 2009, 29:14965-14979.
97. Marta M., et al. Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis. Eur. J. Immunol. 2008, 38:565-575.
98. Prinz M., et al. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J. Clin. Invest. 2006, 116:456-464.
99. Ellestad K.K., et al. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells. J. Immunol. 2009, 183:298-309.
100. Herrmann I., et al. Streptococcus pneumoniae Infection aggravates experimental autoimmune encephalomyelitis via Toll-like receptor 2. Infect. Immun. 2006, 74:4841-4848.
101. Farez M.F., et al. Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE. Nature Immunol. 2009, 10:958-964.
102. Meyer U., et al. A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr. Bull. 2009, 35:959-972.
103. Salaria S., et al. Toll-like receptor pathway gene expression is associated with human immunodeficiency virus-associated neurodegeneration. J. Neurovirol. 2007, 13:496-503.
104. Marta M., et al. Regulation of autoimmune encephalomyelitis by toll-like receptors. Autoimmun. Rev. 2009, 8:506-509.
105. Fu X., et al. Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures. J. Neuroinflammation 2010, 7:43.